Johnson & Johnson

from Wikipedia, the free encyclopedia
Johnson & Johnson

logo
legal form Corporation
ISIN US4781601046
founding 1886
Seat New Brunswick , United States
management
Number of employees 132,200
sales $ 82 billion
Branch Consumer goods
Pharmaceutical products
Medical devices
Diagnostics
Visual aids
Website www.jnj.com
As of December 31, 2019

Company headquarters in New Brunswick

Johnson & Johnson is a global American pharmaceutical and consumer goods manufacturer headquartered in New Brunswick in the US state of New Jersey . The company is listed on the Dow Jones Industrial Average (symbol: JNJ). Johnson & Johnson is one of the largest healthcare companies in the world with sales of $ 71.9 billion and profits of $ 16.4 billion in 2016. The pharmaceutical division operates primarily under the name of Janssen and had sales of 31.4 billion US dollars in 2015. There are also OTC resp. Medical device divisions.

The headquarters of the German branch is in Neuss , the Austrian one in Vienna . There are also other important company locations in Wuppertal , Duisburg and Norderstedt .

Johnson & Johnson employs around 127,000 people in 60 countries worldwide, including around 4,000 in Germany. The products of the Consumer, Medical Device and Pharmaceutical divisions are sold in 175 countries.

The largest shareholders are currently (December 2017) The Vanguard Group (11.18 percent), BlackRock (9.33 percent) and State Street Corporation (8.59 percent). The company's total market capitalization was $ 341.3 billion in mid-2018, making it one of the most valuable companies in the world.

history

The company Johnson & Johnson was founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson.

The focus of business activity in the 1880s was on the manufacture of the first surgical dressing materials. Codman & Shurtleff, founded in Boston in 1838 and thus probably the oldest medical device manufacturer in the world, has been part of Johnson & Johnson since 1964.

Johnson & Johnson achieved great public fame through three disasters that occurred between 1898 and 1906, in which the company's products were used to overcome. During the Spanish-American War , the American army relied on Johnson & Johnson medical products. Johnson & Johnson provided almost everything from surgical gowns to novel, compact stretchers. After the Galveston Hurricane in 1900, Johnson & Johnson made all slightly damaged goods available to pharmacists free of charge. Johnson & Johnson was best known for providing immediate relief after the 1906 San Francisco earthquake . Johnson & Johnson provided emergency medical products as well as hospitals. All products with a purchase price of less than $ 100 were free at this point. Johnson & Johnson thus became the largest “single donor” of this disaster.

After a few people died after taking acetaminophen in Chicago in 1982 , Johnson & Johnson launched a large-scale recall that cost the company an estimated $ 100 to $ 240 million, but was also positively valued by the public and as an example of further development from a pure marketing concept to a social marketing concept. In January 2017, Johnson & Johnson made a takeover bid for Swiss pharmaceutical company Actelion worth $ 30 billion. The takeover was completed in June 2017.

In mid-August 2020, Johnson & Johnson announced that it was taking over US biotech company Momenta. The acquisition is reported to cost $ 6.5 billion.

numbers

Business and employee development (respective fiscal year)
year Sales
in billions of US $
Balance sheet profit
in billion US $
Employees
2005 50.514 10.060 115,600
2006 53,324 11.053 122,200
2007 61.095 10,576 119,200
2008 63.747 12,949 118,700
2009 61.897 12.266 115,500
2010 61,587 13,334 114,000
2011 65.030 9,672 117,900
2012 67.224 10.853 127,600
2013 71.312 13,831 128,100
2014 74.331 16,323 126,500
2015 70.074 15.409 127,100
2016 71.890 16,540 126,400
2017 76,450 1,300 134,000
2018 81,581 15.297 135,100
2019 82.059 15.119 132,200

Great Depression

The crisis did not leave Johnson & Johnson unaffected. In 2008, however, annual sales increased by 2.6 billion US dollars (in 2007 the increase in sales was 7.8 billion US dollars). With the onset of the crisis and massive increases in unemployment in the US (usually loss of health insurance), sales fell for the first time in years. This trend then became apparent in fiscal year 2009, which ended with sales down by $ 1.8 billion. Income fell from $ 12.9 billion in 2008 to $ 12.3 billion in 2009.

Ultimately, however, the crisis hit the company less severely than large parts of the economy. In 2011, the company was able to expand further and opened a new logistics center in Duisburg on 42,000 square meters. Thanks to the use of photovoltaics and waste heat from surrounding industrial plants for heating, the logistics center is considered environmentally friendly.

Company structure in German-speaking countries

Johnson & Johnson is represented in the German-speaking countries Germany, Austria & Switzerland by the following companies.

  • Cilag AG (Switzerland)
  • Cilag GmbH (International)
  • Codman & Shurtleff Inc.
  • Vision Care ACUVUE Norderstedt
  • DePuy Synthes
  • Johnson & Johnson Medical GmbH (formerly Ethicon GmbH)
  • Ethicon Endo-Surgery Inc.
  • Janssen-Cilag International
  • Janssen-Cilag GmbH (Germany)
  • Johnson & Johnson GmbH (Germany)
  • Johnson & Johnson Austria Ges.mbH
  • LifeScan Inc.
  • McNeil GmbH & Co. oHG.
  • Ortho Biotech Products LP
  • Ortho-Clinical Diagnostics GmbH (Germany)
  • Surgical Process Institute Deutschland GmbH (Germany)
  • Synthes

criticism

asbestos

In July 2018, Johnson & Johnson (J&J), Missouri, was fined $ 4.69 billion for decades of selling carcinogenic baby powder. J&J had known about it since the 1970s and did not warn consumers. In response, J&J shares fell 1 percent in after-hours trading. On December 14, 2018, the alleged contents of confidential company papers became known in the course of a court case, from which it emerges that the baby powder of the pharmaceutical company contained small amounts of asbestos from 1971 to the beginning of the 2000s . The company was aware of this and had manipulated the results of its own studies without informing supervisory authorities about the contamination. The stock market price fell at times by over 10 percent, the equivalent of about 45 billion dollars.

Microplastics

Johnson & Johnson still uses microplastics in some products , which causes problems in the environment, especially because they are difficult to break down.

Risperdal

In November 2013, Johnson & Johnson reached a settlement in which $ 2.2 billion was paid to the US government for bribing pharmacists to use the neuroleptic risperdal (risperidone) on demented elderly people, children and the disabled. In December 2016, 13,000 men filed class actions against Johnson & Johnson in the United States. They developed gynecomastia (men's breasts) as a side effect of the drug Risperdal .

Opioid crisis

Johnson & Johnson has, in many cases, been directly linked to the opioid epidemic in the United States , which led to a public health crisis in the United States. In May 2019, a historic opioid trial began against Johnson & Johnson in the US state of Oklahoma . The group is accused of having made billions in profits with synthetic opiates - for this it has manipulated studies, operated deceptive marketing and lied in advertising. Johnson & Johnson explicitly targeted men under 40 who are most affected by the addiction. When demand then increased, the group bought opium poppy growers in Australia in order to benefit from the entire value chain .

In August 2019, the Oklahoma court sentenced the pharmaceutical company to pay $ 572 million in compensation. By misleading advertisements of highly addictive pain relievers, J&J "has harmed the health and safety of thousands of Oklahoma citizens," the verdict said.

Web links

Commons : Johnson & Johnson  - collection of pictures, videos and audio files

Individual evidence

  1. a b Annual Report 2019 , accessed on May 12, 2020
  2. ^ A b Johnson & Johnson on the Forbes Top Regarded Companies List . In: Forbes . ( forbes.com [accessed November 20, 2017]).
  3. a b c Johnson & Johnson Reports 2015 Fourth-Quarter Results PM by J&J January 26, 2016, accessed February 11, 2016
  4. jnj.de , www.jnj.de, accessed on February 15, 2014.
  5. (JNJ) Summary of Shareholder Structure - NASDAQ.com. Retrieved December 31, 2017 (American English).
  6. John E. Douglas , Mark Olshaker: The Anatomy of Motive - The FBI's Legendary Mindhunter Explores the Key to Understanding and Catching Violent Criminals . Scribner, New York City 1999, ISBN 0-684-84598-9 , pp. 103-104 (English).
  7. ^ Philip Kotler , Gary Armstrong: Principles of Marketing. Prentice Hall International, 2nd Edition, ISBN 0-13-700669-1 , p. 23.
  8. ^ Johnson & Johnson Completes Acquisition of Actelion. In: cws.huginonline.com. June 16, 2017, archived from the original on December 31, 2017 ; accessed on August 30, 2019 (English).
  9. JOHNSON & JOHNSON TO ACQUIRE ACTELION FOR $ 30 BILLION WITH SPIN- OUT OF NEW R&D COMPANY ( Memento of the original dated February 7, 2017 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. PM J&J of January 26, 2017, p. Roadmap, accessed February 7, 2017 @1@ 2Template: Webachiv / IABot / files.shareholder.com
  10. Pharmaceutical industry: next billion dollar deal - J&J purchases for 6.5 billion dollars. Retrieved August 19, 2020 .
  11. ^ Johnson & Johnson Revenue 2006-2018 | JNJ. Retrieved October 22, 2018 .
  12. Company profile . Retrieved October 22, 2018 .
  13. Johnson & Johnson - Employees until 2017 | Statistics. Retrieved December 9, 2018 .
  14. Places: Ecological Responsibility. In: jnjgermany.de. Johnson & Johnson, accessed August 30, 2019 .
  15. Country overview on the manufacturer's website of Johnson & Johnson (USA) ( Memento from August 17, 2008 in the Internet Archive ) on jnj.com
  16. Johnson & Johnson: Billion fine for US pharmaceutical company. In: tagesschau.de . July 13, 2018, archived from the original on July 13, 2018 ; accessed on July 14, 2018 .
  17. US consumer goods giant: Asbestos in baby powder? Johnson & Johnson loses $ 45 billion in market value. Retrieved December 14, 2018 .
  18. Microplastics, the invisible danger. (PDF) BUND , July 2017, accessed on January 8, 2018 .
  19. Microplastics - The Dangerous Consequences of Invisible Plastics ( Memento of the original from January 9, 2018 in the Internet Archive ) Info: The archive link has been inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. In: plusminus . November 15, 2017, accessed January 8, 2018. @1@ 2Template: Webachiv / IABot / www.daserste.de
  20. Article dealing with the aggressive and illegal marketing of risperidone: America's Most Admired Lawbreaker . In: The Huffington Post , September 2015. 
  21. tagesschau.de: Schizophrenia remedies for dementia - pharmaceutical giant pays billions in fine ( Memento from November 5, 2013 in the Internet Archive ), November 4, 2013.
  22. ^ Attorney General Eric Holder Delivers Remarks at the Johnson & Johnson Press Conference .
  23. Waltraud Messmann: 13,000 men grew breasts after taking medication .
  24. Thorsten Schröder: Addiction: Too high to work . In: The time . August 8, 2017, ISSN  0044-2070 ( zeit.de [accessed June 24, 2019]).
  25. Johnson & Johnson opioids helped create 'worst man-made public health crisis in history,' Oklahoma says in court. Retrieved June 24, 2019 .
  26. Chris McGreal: Johnson & Johnson faces multibillion opioids lawsuit that could upend big pharma . In: The Guardian . June 23, 2019, ISSN  0261-3077 ( theguardian.com [accessed June 24, 2019]).
  27. ^ Johnson & Johnson Convicted of Mishandling Pain Relief Medicine , Spiegel Online, August 26, 2019.